As I see it both companies are have staked their success or otherwise on what could be described as 'trans dermal compound delivery technologies' - POH with TPM technologies and OBJ with magnetic micro-array technologies. Right or wrong?
I imagine that these two categories of technology will have potientially overlapping and non overlapping applications - particularly in relation to pharmaceuticals and cosmetics. (e.g. Apparently OBJ have investigated the effect of their technology on the application of Voltaren topical diclofenac)
Is anyone interested in contributing their opinions on comparison of the likely values of the two technologies and/or make predictions regarding the longer term future of both companies (say 3-5 years hence). It would appear that OBJ has recently managed a good head start. Will it be maintained?
If my questions are too general or too vague just ignore.
poh cf obj technologies
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $369 | 138.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 96190952 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 59980558 | 19 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |